Tango Therapeutics, Inc. (NASDAQ:TNGX) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Robert Azelby Other companies: Autolus Therapeutics plc (Director · Since at least Mar 18, 2026); Terns Pharmaceuticals, Inc. (Director · Since at least Feb 20, 2025); Cardinal Health, Inc. (Director · Since at least Mar 1, 2024); ADC Therapeutics SA (Director · Since at least Jan 2, 2024); Aduro Biotech Inc (Director · Apr 10, 2023 – Aug 11, 2023 · Past); Climb Bio, Inc. (President & CEO, Director · Aug 9, 2021 – Oct 31, 2022 · Past); Immunomedics Inc (Director · Feb 26, 2020 – Oct 23, 2020 · Past); Clovis Oncology Inc (Director · Oct 11, 2018 – Jun 10, 2021 · Past); Alder BioPharmaceuticals Inc (President and CEO, Director · Jun 13, 2018 – Oct 22, 2019 · Past); Cascadian Therapeutics Inc (Director · Mar 31, 2017 – Mar 9, 2018 · Past); Juno Therapeutics Inc (EVP & Chief Commercial Officer · Nov 1, 2015 – Mar 5, 2018 · Past) | Chairman; Former President and CEO, Eliem Therapeutics, Inc. · Since at least Jun 19, 2026 |
| Richard Heyman Other companies: Enliven Therapeutics, Inc. (Director · Since at least Feb 23, 2023); PMV Pharmaceuticals, Inc. (Director · Since at least Sep 24, 2020); ORIC Pharmaceuticals, Inc. (Chairman · Since at least Apr 23, 2020); RayzeBio, Inc. (Director · Sep 14, 2023 – Feb 26, 2024 · Past); Kineta Inc. (Director · Dec 22, 2020 – Jun 2, 2021 · Past); Metacrine Inc (Director · Sep 15, 2020 – May 18, 2022 · Past); Gritstone bio, Inc. (Director · Sep 27, 2018 – Jun 17, 2022 · Past) | Director · Sep 2, 2020 – Sep 2, 2020 · Past |
| Daniella Beckman Other companies: Upstream Bio, Inc. (Member, Board of Directors · Since at least Oct 10, 2024); Blueprint Medicines Corp (Director · Since at least Dec 8, 2021); Vor Biopharma Inc. (Chair of the Audit Committee · Since at least Feb 4, 2021); 5 01 Acquisition Corp (Director · Oct 13, 2020 – Oct 16, 2020 · Past); Translate Bio Inc (Director · Jun 18, 2019 – Sep 14, 2021 · Past) | Chief Financial Officer · Since at least Aug 10, 2021 |
| Alexis Borisy Other companies: Parabilis Medicines, Inc. (Lead Independent Director; Chairman, Nextech Invest; Chairman, Curie.Bio · Since at least Jun 9, 2026); Revolution Medicines, Inc. (Director · Since at least Jun 26, 2025); Blueprint Medicines Corp (Director · Since at least Jun 18, 2025); Relay Therapeutics, Inc. (Director · Since at least Jun 6, 2025) | Director · Since at least Jun 5, 2025 |
| Charles Baum Other companies: Acrivon Therapeutics, Inc. (Director · Since at least Jun 22, 2023); PMV Pharmaceuticals, Inc. (Director · Since at least Apr 1, 2021); Poseida Therapeutics Inc (Director · May 16, 2022 – Jan 8, 2025 · Past); Immunomedics Inc (Director · Feb 23, 2019 – Oct 23, 2020 · Past) | Director · Sep 2, 2020 – Sep 2, 2020 · Past |
| Reid Huber Other companies: Rapport Therapeutics, Inc. (Partner, Third Rock Ventures · Since at least Jun 6, 2024); CARGO Therapeutics, Inc. (Director · Since at least Nov 9, 2023); Bellicum Pharmaceuticals Inc (Director · Dec 17, 2014 – Jan 3, 2023 · Past); Incyte Corporation (EVP, Chief Scientific Officer · Apr 27, 2014 – Jul 16, 2018 · Past) | Director · Aug 10, 2021 – Jun 6, 2023 · Past |
| Barbara Weber Other companies: Parabilis Medicines, Inc. (Director · Since at least Jun 9, 2026); OPY Acquisition I Corp (Director · Oct 26, 2021 – Oct 26, 2021 · Past); Revolution Medicines, Inc. (Director · Feb 12, 2020 – Oct 8, 2024 · Past) | Director, Executive Chair, Director · Since at least Aug 10, 2021 |
| Sung Lee Other companies: Cytokinetics, Incorporated (EVP, Chief Financial Officer · Since at least Apr 26, 2024); Vir Biotechnology, Inc. (EVP & Chief Financial Officer · Mar 27, 2023 – Mar 27, 2024 · Past); Sangamo Therapeutics, Inc. (EVP, Chief Financial Officer · Oct 31, 2019 – Nov 25, 2020 · Past) | Executive Vice President and Chief Financial Officer, Cytokinetics · Since at least Jan 2, 2026 |
| Aaron I Davis Other companies: Rain Oncology Inc (Director · Apr 22, 2021 – Jan 26, 2024 · Past); Iteos Therapeutics Inc (Director · Jul 23, 2020 – Jun 11, 2024 · Past) | Director · Jun 8, 2022 – Aug 11, 2023 · Past |
| Lesley Ann Calhoun Other companies: Aligos Therapeutics, Inc. (See Remarks · Since at least Oct 15, 2020); Global Blood Therapeutics Inc (See Remarks · Dec 31, 2017 – May 26, 2020 · Past) | EVP, Aligos Therapeutics · Since at least Aug 10, 2021 |
| Matthew Gall Other companies: Kalaris Therapeutics, Inc. (Chief Financial Officer · Since at least Nov 3, 2025); Iteos Therapeutics Inc (Chief Financial Officer · Since at least Jul 23, 2020) | Chief Financial Officer · Since at least Apr 15, 2026 |
| Adam Crystal Other companies: C4 Therapeutics, Inc. (Chief Medical Officer · May 25, 2022 – Jan 30, 2023 · Past) | President, Research & Development · Since at least Feb 27, 2023 |
| James B Avery Other companies: Inseego Corp. (Director · Aug 6, 2018 – Feb 5, 2020 · Past) | Director · Oct 6, 2020 – Oct 6, 2020 · Past |
| Joseph Lewis Other companies: Inseego Corp. (Director · Aug 9, 2019 – Aug 9, 2019 · Past) | Director · Aug 11, 2023 – Aug 11, 2023 · Past |
| Mace Rothenberg Other companies: Surrozen, Inc. (Director · Since at least Aug 11, 2021) | Director · Since at least Aug 10, 2021 |
| Aaron Weitzman | Chief Medical Officer · Dec 1, 2022 – Dec 1, 2022 · Past |
| Alan Huang | Chief Scientific Officer · Aug 10, 2021 – Mar 1, 2023 · Past |
| Douglas Barry | General Counsel · Mar 1, 2023 – Feb 4, 2025 · Past |
| Fatma Ocak | Chief Commercialization Officer · Since at least Aug 11, 2026 |
| Janice Kapty | SVP, Corporate Strategy and Project Leadership · Since at least Apr 15, 2026 |
| Jessica Newcomb | Principal Accounting Officer · Since at least Sep 22, 2026 |
| John B Ketchum | Director · Since at least Aug 29, 2023 |
| Julie Carretero | Chief Human Resources Officer · Since at least Nov 4, 2026 |
| Julie Fogarty | SVP, General Counsel · Since at least Nov 4, 2026 |
| Kanishka Pothula | Director · Nov 6, 2023 – Nov 6, 2023 · Past |
| Malte Peters | President & Chief Executive Officer, Tango Therapeutics · Since at least Nov 3, 2026 |
| Marc Rudoltz | Chief Medical Officer · Oct 18, 2021 – Nov 1, 2021 · Past |
| Philippe Serrano | Chief Regulatory Officer · Since at least Mar 5, 2026 |
| Yen-Ching Chua | Chief Development Operations Officer · Since at least Apr 15, 2026 |